Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Return on Capital Employed [ROCE] (2025)

Updated

Innocan Pharma (INNPF) recorded Return on Capital Employed [ROCE] of 13.26% in the quarter ended Dec 31, 2025, down 2.04 percentage points from the prior quarter.

Analysis

Innocan Pharma (INNPF) Return on Capital Employed [ROCE] (2025) Analysis & Trends

For the year ended Dec 31, 2025, Innocan Pharma reported Return on Capital Employed [ROCE] of 14.70%, down 6.57 percentage points from the prior year.

  • Across earlier years, Return on Capital Employed [ROCE] came in at 21.27% in the year ended Dec 31, 2024.
  • Per Business Quant, the preceding three quarters came in at 15.30% (quarter ended Sep 30, 2025), 35.27% (quarter ended Jun 30, 2025) and 39.78% (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn 13.26%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 13.26%
Sep 30, 2025 15.30%
Jun 30, 2025 35.27%
Mar 31, 2025 39.78%
API Access

Innocan Pharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INNPF&period=max&api_key=YOUR_API_KEY